Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers

Journal of Biomedical Nanotechnology

Volumn 9, Issue 6, 2013, Pages 965-975

  Long, Qida ^a,b   Xie, Yao ^a,c   Huang, Yanqing ^b   Wu, Qinjie ^a   Zhang, HeCheng ^d   Xiong, Shaoquan ^a   Liu, Yingwei ^a,c   Chen, Lijuan ^a   Wei, Yuquan ^a   Zhao, Xia ^a   Gong, Changyang ^a  

^a SICHUAN UNIVERSITY   (China)

^b GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d Xinxiang University   (China)

Author keywords

Antiangiogenesis; Apoptosis; Cisplatin resistant ovarian cancer; Liposomes; Quercetin

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTIANGIOGENESIS; CLINICAL EFFICIENCY; IMMUNOHISTOCHEMISTRY; INDUCED APOPTOSIS; MICROVESSEL DENSITY; OVARIAN CANCERS; QUERCETIN;

CELL DEATH; CELL PROLIFERATION; DISEASES; DRUG PRODUCTS; FATTY ACIDS; FLAVONOIDS; LIPOSOMES; PHENOLS; TUMORS;

PLATINUM COMPOUNDS;

CISPLATIN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CANCER SIZE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG RELEASE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; SUSTAINED DRUG RELEASE; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOCAPSULES; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; POLYETHYLENE GLYCOLS; QUERCETIN; TREATMENT OUTCOME;

EID: 84877827656     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1596     Document Type: Article

References (41)

1. R. Shireen, D. Brennan, G. Flannelly, D. Fennelly, P. Lenehan, and M. Foley, Survival in women with ovarian cancer before and after the introduction of adjuvant paclitaxel; a 25-year, single institution review. Irish Medical Journal 105, 47 (2012).
2. C. A. Sherman-Baust, K. G. Becker, W. H. Wood Iii, Y. Zhang, and P. J. Morin, Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. Journal of Ovarian Research 4, 21 (2011).
3. S. Tammam, S. Mathur, and N. Afifi, Preparation and biopharmaceutical evaluation of tacrolimus loaded biodegradable nanoparticles for liver targeting. Journal of Biomedical Nanotechnology 8, 439 (2012).
4. E. A. Leite, A. M. Q. Lana, C. Junior, D. Alvaro, L. G. V. Coelho, and M. C. De Oliveira, Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice. Journal of Biomedical Nanotechnology 8, 229 (2012).
5. J. Lu, L. V. Papp, J. Fang, S. Rodriguez-Nieto, B. Zhivotovsky, and A. Holmgren, Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity. Cancer Res. 66, 4410 (2006).
6. A. A. Dihal, R. A. Woutersen, B. van Ommen, I. M. Rietjens, and R. H. Stierum, Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line caco-2. Cancer Lett 238, 248 (2006).
7. K. Senthilkumar, R. Arunkumar, P. Elumalai, G. Sharmila, D. N. Gunadharini, S. Banudevi, G. Krishnamoorthy, C. S. Benson, and J. Arunakaran, Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem. Funct. 29, 87 (2011).
8. J. Michaud-Levesque, N. Bousquet-Gagnon, and R. Beliveau, Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp. Cell Res. (2012).
9. Y. M. Yang, Y. O. Son, S. A. Lee, Y. M. Jeon, and J. C. Lee, Quercetin inhibits alpha-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytotherapy research: PTR 25, 1166 (2011).
10. R. K. Srivastava, S. N. Tang, W. Zhu, D. Meeker, and S. Shankar, Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front Biosci. (Elite Ed) 3, 515 (2011).
11. T. Samouel, K. Fadlalla, T. Turner, and T. E. Yehualaeshet, The flavonoid quercetin transiently inhibits the activity of taxol and noco-dazole through interference with the cell cycle. Nutrition and Cancer 62, 1025 (2010).
12. M. Linsalata, A. Orlando, C. Messa, M. G. Refolo, and F. Russo, Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis. Anticancer Res. 30, 3501 (2010).
13. S. J. Duthie, W. Johnson, and V. L. Dobson, The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutation Res. 390, 141 (1997).
14. M. Yoshida, M. Yamamoto, and T. Nikaido, Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 52, 6676 (1992).
15. P. Wang, K. Zhang, Q. Zhang, J. Mei, C. J. Chen, Z. Z. Feng, and D. H. Yu, Effects of quercetin on the apoptosis of the human gastric carcinoma cells. Toxicology in vitro: An international journal published in association with BIBRA 26, 221 (2012).
16. R. E. Wang, J. L. Kao, C. A. Hilliard, R. K. Pandita, J. L. Roti Roti, C. R. Hunt, and J. S. Taylor, Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. J. Med. Chem. 52, 1912 (2009).
17. Y. Q. Wei, X. Zhao, Y. Kariya, H. Fukata, K. Teshigawara, and A. Uchida, Induction of apoptosis by quercetin: Involvement of heat shock protein. Cancer Res. 54, 4952 (1994).
18. A. J. Vargas, S. Sittadjody, T. Thangasamy, E. E. Mendoza, K. H. Limesand, and R. Burd, Exploiting tyrosinase expression and activity in melanocytic tumors: Quercetin and the central role of p53. Integrative Cancer Therapies 10, 328 (2011).
19. Z. P. Yuan, L. J. Chen, L. Y. Fan, M. H. Tang, G. L. Yang, H. S. Yang, X. B. Du, G. Q. Wang, W. X. Yao, Q. M. Zhao, B. Ye, R. Wang, P. Diao, W. Zhang, H. B. Wu, X. Zhao, and Y. Q. Wei, Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12, 3193 (2006).
20. H. Sharma, S. Sen, and N. Singh, Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biology and Therapy 4, 949 (2005).
21. K. G. Louie, B. C. Behrens, T. J. Kinsella, T. C. Hamilton, K. R. Grotzinger, W. M. McKoy, M. A. Winker, and R. F. Ozols, Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res. 45, 2110 (1985).
22. Q. Baowen, Z. Yulin, W. Xin, X. Wenjing, Z. Hao, C. Zhizhi, D. Xingmei, Z. Xia, W. Yuquan, and C. Lijuan, A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur. J. Pharmacol. 642, 134 (2010).
23. C. Y. Gong, C. Wang, Q. J. Wu, Y. J. Wang, F. Luo, and Z. Qian, Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale 4, 3095 (2012).
24. C. Y. Gong, X. W. Wei, X. H. Wang, Y. J. Wang, G. Guo, Y. Q. Mao, F. Luo, and Z. Y. Qian, Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology 21, 215103 (2010).
25. Y. Liu, L. Chen, X. He, L. Fan, G. Yang, X. Chen, X. Lin, L. Du, Z. Li, H. Ye, Y. Mao, X. Zhao, and Y. Wei, Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 18, 652 (2008).
26. K. M. Henkels and J. J. Turchi, Induction of apoptosis in cisplatin-sensitive and-resistant human ovarian cancer cell lines. Cancer Res. 57, 4488 (1997).
27. C. Xu, H. Nishi, and K. Isaka, A case of uterine cervical carcinosarcoma recurrence who obtained a clinically complete response by ifosfamide, doxorubicin and cisplatin. European Journal of Gynaecological Oncology 32, 119 (2011).
28. S. A. Heasman, L. Zaitseva, K. M. Bowles, S. A. Rushworth, and D.J. Macewan, Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1. Oncotarget 2, 658 (2011).
29. K. Eichele, R. Ramer, and B. Hinz, Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells. Oncogene 27, 3032 (2008).
30. I. Muller, D. Niethammer, and G. Bruchelt, Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int. J. Mol. Med. 1, 491 (1998).
31. W. Hu, F. Wang, J. Tang, X. Liu, Z. Yuan, C. Nie, and Y. Wei, Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. The Journal of Biological Chemistry 287, 68 (2012).
32. Z. Yuan, F. Wang, Z. Zhao, X. Zhao, J. Qiu, C. Nie, and Y. Wei, BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and-resistant ovarian cancer cells. PLoS One 6, e20586 (2011).
33. H. Zhang, M. Zhang, L. Yu, Y. Zhao, N. He, and X. Yang, Antitumor activities of quercetin and quercetin-5',8-disulfonate in human colon and breast cancer cell lines. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 50, 1589 (2012).
34. T. Miura, S. Muraoka, and Y. Fujimoto, Inactivation of creatine kinase induced by quercetin with horseradish peroxidase and hydrogen peroxide. pro-oxidative and anti-oxidative actions of quercetin. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 41, 759 (2003).
35. Z. J. Sun, G. Chen, X. Hu, W Zhang, Y. Liu, L. X. Zhu, and Y. F. Zhao, Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: Its inhibition by quercetin. Apoptosis: An International Journal on Programmed Cell Death 15, 850 (2010).
36. E. J. Kim, C. H. Choi, J. Y. Park, S. K. Kang, and Y. K. Kim, Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res. 33, 971 (2008).
37. S. H. Akbas, M. Timur, and T. Ozben, The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells. J. Surg. Res. 125, 49 (2005).
38. K. L. Reckamp, Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer. Cancer Lett. (2012).
39. Y. Ren, D. Fleischmann, K. Foygel, L. Molvin, A. M. Lutz, A. C. Knoong, R. B. Jehfferey, L. Tian, and J. K. Willmann, Antiangiogenic and radiation therapy: Early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Investigative Radiology 47, 25 (2012).
40. E. Alba, Antiangiogenic therapy of breast cancer: How did we get here?: The road not taken. Clinical & translational oncology: Official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 13, 765 (2011).
41. R. S. Kerbel, Reappraising antiangiogenic therapy for breast cancer. Breast 3(20 Suppl), S56 (2011).